Implantable device for the sustained release of a polypeptide

Details Implantable device for the sustained release of a polypeptide Implantable device for the sustained release of a polypeptide

2009-06-24

2011-12-06

Chandra, Gyan (Department: 1646)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C514S021700, C424S422000, C424S460000

Reexamination Certificate

active

08071537

ABSTRACT:
Described herein are implantable devices, formulations and methods of making implantable devices for the release of a polypeptide from an implantable device, and methods of use thereof.

REFERENCES:
patent: 2513014 (1950-06-01), Fields
patent: 3921632 (1975-11-01), Bardani
patent: 4131604 (1978-12-01), Szycher
patent: 4285987 (1981-08-01), Ayer et al.
patent: 4298002 (1981-11-01), Ronel et al.
patent: 4386039 (1983-05-01), Szycher
patent: 4523005 (1985-06-01), Szycher
patent: 4743673 (1988-05-01), Johnston et al.
patent: 4751133 (1988-06-01), Szycher et al.
patent: 4846793 (1989-07-01), Leonard et al.
patent: 4871094 (1989-10-01), Gall et al.
patent: 4954587 (1990-09-01), Mueller
patent: 4959217 (1990-09-01), Sanders et al.
patent: 4994028 (1991-02-01), Leonard et al.
patent: 5004614 (1991-04-01), Staniforth
patent: 5035891 (1991-07-01), Runkel et al.
patent: 5254662 (1993-10-01), Szycher et al.
patent: 5266325 (1993-11-01), Kuzma et al.
patent: 5273752 (1993-12-01), Ayer et al.
patent: 5292515 (1994-03-01), Moro et al.
patent: 5342622 (1994-08-01), Williams et al.
patent: 5354835 (1994-10-01), Blair
patent: 5431921 (1995-07-01), Thombre
patent: 5464933 (1995-11-01), Bolognesi et al.
patent: 5468811 (1995-11-01), Moro et al.
patent: 5614223 (1997-03-01), Sipos
patent: 5637309 (1997-06-01), Tajima et al.
patent: 5686411 (1997-11-01), Gaeta et al.
patent: 5756127 (1998-05-01), Grisoni et al.
patent: 5817343 (1998-10-01), Burke
patent: 5854127 (1998-12-01), Pan
patent: 5876761 (1999-03-01), Bodmer et al.
patent: 5894458 (1999-04-01), Takizawa et al.
patent: 6087334 (2000-07-01), Beeley et al.
patent: 6143718 (2000-11-01), Kolterman et al.
patent: 6159490 (2000-12-01), Deghenghi
patent: 6313254 (2001-11-01), Meijs et al.
patent: 6337318 (2002-01-01), Trigg et al.
patent: 6361797 (2002-03-01), Kuzma et al.
patent: 6417164 (2002-07-01), Kolterman et al.
patent: 6579851 (2003-06-01), Goeke et al.
patent: 6602694 (2003-08-01), Albrandt et al.
patent: 6770623 (2004-08-01), Chang et al.
patent: 6872700 (2005-03-01), Young et al.
patent: 6942264 (2005-09-01), Mendez
patent: 6969480 (2005-11-01), Dalton et al.
patent: 7008927 (2006-03-01), Ochiai et al.
patent: 7056887 (2006-06-01), Coolidge et al.
patent: 7101853 (2006-09-01), Young et al.
patent: 7105489 (2006-09-01), Hathaway
patent: 7115569 (2006-10-01), Beeley et al.
patent: 7118737 (2006-10-01), Kochendoerfer et al.
patent: 7153825 (2006-12-01), Young et al.
patent: 7220721 (2007-05-01), Beeley et al.
patent: 7259136 (2007-08-01), Hathaway et al.
patent: 7271238 (2007-09-01), Gaeta et al.
patent: 7452868 (2008-11-01), Kuzma et al.
patent: 2002/0141985 (2002-10-01), Pittner et al.
patent: 2003/0036504 (2003-02-01), Kolterman et al.
patent: 2004/0002454 (2004-01-01), Coolidge et al.
patent: 2004/0071736 (2004-04-01), Quinn et al.
patent: 2004/0097419 (2004-05-01), Petersen et al.
patent: 2005/0037078 (2005-02-01), Kuo et al.
patent: 2005/0143303 (2005-06-01), Quay et al.
patent: 2005/0287320 (2005-12-01), Dalton et al.
patent: 2006/0019903 (2006-01-01), Kuzma et al.
patent: 2006/0030528 (2006-02-01), Hathaway et al.
patent: 2006/0035836 (2006-02-01), Coolidge et al.
patent: 2006/0067911 (2006-03-01), Nilsson et al.
patent: 2006/0122106 (2006-06-01), Gedulin et al.
patent: 2006/0148713 (2006-07-01), Beeley et al.
patent: 2006/0204540 (2006-09-01), Kuzma et al.
patent: 2006/0233747 (2006-10-01), Kochendoerfer et al.
patent: 2006/0293232 (2006-12-01), Levy et al.
patent: 2007/0010656 (2007-01-01), Beeley et al.
patent: 2008/0311170 (2008-12-01), Kuzma et al.
patent: 2009/0035343 (2009-02-01), Kuzma et al.
patent: 2009/0087470 (2009-04-01), Kuzma et al.
patent: 0 246 653 (1987-11-01), None
patent: 0 314 206 (1989-05-01), None
patent: 0 384 646 (1990-08-01), None
patent: 0 551 699 (1993-07-01), None
patent: 0 645 136 (1995-03-01), None
patent: 821383 (1937-12-01), None
patent: 1 306 541 (1973-02-01), None
patent: 05-269759 (1993-10-01), None
patent: 05-269760 (1993-10-01), None
patent: 07-097338 (1995-04-01), None
patent: 07-252166 (1995-10-01), None
patent: 11-506730 (1999-06-01), None
patent: 2002-535452 (2002-10-01), None
patent: 245383 (1994-05-01), None
patent: WO-96/40049 (1996-12-01), None
patent: WO-98/44964 (1998-10-01), None
patent: WO-00/44356 (2000-08-01), None
patent: WO-02/49573 (2002-06-01), None
patent: WO-02/078597 (2002-10-01), None
patent: WO-2004/071736 (2004-08-01), None
patent: WO-2005/013936 (2005-02-01), None
patent: WO-2005/041873 (2005-05-01), None
patent: WO-2006/099288 (2006-09-01), None
patent: WO-2007/028394 (2007-03-01), None
patent: WO-2008/061355 (2008-05-01), None
patent: WO-2008/134475 (2008-11-01), None
International Preliminary Report on Patentability received for PCT/US2009/048475 dated Jan. 5, 2011.
Notice of Allowance received for U.S. Appl. No. 12/490,979 dated Feb. 4, 2011.
Shi et al., Expert Opin. Drug Deliv., “Current Advances in Sustained-Release Systems for Parenteral Drug Delivery,” vol. 2(6), 2005, pp. 1039-1058.
U.S. Appl. No. 12/490,979, filed Jun. 24, 2009, Kuzma et al.
“RxMed: Pharmaceutical Information-Sandostatin LAR DEPOT” [online], Jan. 6, 2003 [retrieved Aug. 16, 2006]; http://www.rxmed.com.
Barradell, L. B. et al., “Histrelin: A Review of its Pharmacological Properties and Therapeutic Role in Central Precocious Puberty,” Drugs, vol. 45, No. 4, Apr. 1993, pp. 570-588; published by Adis International Limited.
Berge, et al., “Pharmaceutical Salts,” Journal of Pharmaceutical Sciences, vol. 66, No. 1, Jan. 1977, pp. 1-19.
Bevan et al., Primary Medical Therapy for Acromegaly: An Open, Prospective, Multicenter Study of the Effects of Subcutaneous and Intramuscular Slow-Release Octreotide on Growth Hormone, Insulin-Like Growth Factor-L, and Tumor Size, J. Clin. Endoc. Metab,. 87(10), 2002, pp. 4554-4563.
Chinese Office Action corresponding to CN 2006800160292, dated Sep. 4, 2009, 8 pages.
Eurasian Patent Office Decision on Patentability corresponding to EU 200701956/28, dated Jan. 21, 2009, 6 pages.
New Zealand Patent Office Examination Report corresponding to NZ 561400, dated Jul. 28, 2009, 2 pages.
Feuillan, P. P. et al., “Follow-up of children and young adults after GnRH-agonist therapy for central precocious puberty,” J. Endocrinol. Invest., vol. 24, 2001, pp. 734-736; published by Editrice Kurtis.
Higuchi, et al., Pro-Drugs as Novel Drug Delivery Systems: A.C.S Symposium Series, American Chemical Society, Washington, DC, 1975.
International Search Report and Written Opinion, PCT/US2009/050215, dated Nov. 25, 2009, 11 pgs.
International Search Report, PCT/US00/01664, dated Jul. 13, 2000, 1 pg.
International Search Report, PCT/US06/08891, dated Dec. 4, 2006, 2 pgs.
International Search Report, PCT/US2005/021368, dated Oct. 23, 2006, 3 pgs.
International Search Report, PCT/US2008/061511, dated Nov. 8, 2009, 2 pgs.
Lan NaLee, “Volume of Blood in a Human,” from http://hypertextbook.com/facts/1998/LanNaLee.shtml, (1998) updated (2001).
Langer, “Implantable Controlled Release Systems,” Pharmac. Ther. (1983), vol. 21, p. 35-51.
M. F. Refojo, et al., “Microscopic Destermination of the Penetration of Proteins and Polysaccharides into Poly(hydroxyethyl Methacrylate) and similar Hydrogels,” Journal of Polymer Science, Polymer Symposium, vol. 66, (1979), pp. 227-237.
P. E. Nielsen et al., “Peptide Nucleic Acid (PNA). A DNA Mimic with a Peptide Backbone,” Bioconjugate Chem., vol. 5, No. 1, 1994, pp. 3-7.
P. Kuzma et al., U.S. PTO Office Action, U.S. Appl. No. 11/155,822 dated Jan. 22, 2008, 12 pgs.
P. Kuzma et al., U.S. PTO Office Action, U.S. Appl. No. 11/155,822 dated Feb. 18, 2009, 11 pgs.
P. Kuzma et al., U.S. PTO Office Action, U.S. Appl. No. 11/155,822 datedOct. 13, 2009, 21 pgs.
Remington's Pharmaceutical Sciences, Osol., A. ed., Mack Publishing Co., (1980).
Roche, ed., Bioreversible Carriers in Drug Design: Theory and Application, Pergamon Press, New York, 1987.
S. W. Kim et al., “Water in Polymers—Solute Permeation Through Hydrogel Membranes,” AC

Affiliated with

Also associated with

Rating

Implantable device for the sustained release of a polypeptide does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Implantable device for the sustained release of a polypeptide, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Implantable device for the sustained release of a polypeptide will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4255052